Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent...

Area of Science:

• Cardiology
• Biomarkers in Cardiovascular Disease

Background:

• Unstable angina is a critical condition requiring prompt intervention.
• Coronary artery stent implantation is a common treatment for unstable angina.
• C-reactive protein is an inflammatory marker with potential prognostic value in cardiovascular disease.

Purpose of the Study:

• To investigate the association between baseline C-reactive protein (CRP) levels and 12-month clinical outcomes.
• To determine if CRP levels can predict cardiac events in patients with unstable angina treated with coronary stents.

Main Methods:

• Prospective study design.
• Inclusion of patients with unstable angina and one-vessel coronary disease.
• Successful coronary artery stent implantation.
• Measurement of baseline serum C-reactive protein levels.
• 12-month follow-up for cardiac events.

Main Results:

• Patients with normal baseline C-reactive protein levels exhibited a significantly lower risk of cardiac events.
• Normal CRP levels identified a low-risk subgroup among patients with unstable angina and one-vessel disease.
• Successful stent implantation was achieved in all participants.

Conclusions:

• Baseline C-reactive protein levels are a valuable predictor of 12-month outcomes in unstable angina patients undergoing coronary stent implantation.
• Normal CRP levels can help identify patients at low risk for future cardiac events, guiding clinical management.
• The study highlights the prognostic significance of CRP in the context of interventional cardiology.